Michael J. Kadan - Concepedia

Concepedia

Author

Michael J. Kadan

Research Institute for Genetic and Human Therapy

Also Known As

Michael J. Kadan, Michael Kadan

24

Publications

1.1K

Citations

12

H-Index

37

Concepts

All Affiliations

Research Institute for Genetic and Human Therapy Lentigen Technology (United States)Case Western Reserve University University Hospitals Seidman Cancer Center University of Washington

MJ

About

Michael J. Kadan is an author at Research Institute for Genetic and Human Therapy specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	841
2	Engineering	1	1	73
3	Health Sciences	1	1	13
4	Biomedical Engineering	1	1	73
5	Biomolecular Engineering	1	1	73

Michael J. Kadan

×

14

Publications

1.1K

Citations

12

H-Index

	Year	Citations
Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial Nirav N. Shah, Bryon D. Johnson, Dina Schneider, Nature Medicine Cancer ImmunosurveillanceDose EscalationMedicineImmunologyExpansion Trial	2020	439
Intraocular expression of endostatin reduces VEGF‐induced retinal vascular permeability, neovascularization, and retinal detachment Kyoichi Takahashi, Yoshitsugu Saishin, Yumiko Saishin, The FASEB Journal Ocular DiseaseImmunologyEndostatin Gene TransferRetinal DetachmentTumor Biology	2003	130
Sustained Phenotypic Correction of Murine Hemophilia A by In Vivo Gene Therapy Sheila Connelly, J. Andrews, Angela Gallo, Blood	1998	106
Factors Affecting Retroviral Vector Function and Structural Integrity Jeanne R. McLachlin, Nannette Mittereder, Mary Beth Daucher, Virology Retroviral Vector FunctionViral ReplicationHuman RetrovirusVirologyHiv	1993	85
Optimization of the Generation and Propagation of Gutless Adenoviral Vectors Kiran Sakhuja, P. Seshidhar Reddy, Shanthi Ganesh, Human Gene Therapy Gutless Vector PropagationViral ReplicationEngineeringMolecular VirologyBioreactor Technology	2003	73
Generation and Characterization of E1/E2a/E3/E4-Deficient Adenoviral Vectors Encoding Human Factor VIII J. Andrews, Michael J. Kadan, M Gorziglia, Molecular Therapy Transgene ExpressionImmunologyPathologyImmune SystemCancer-associated Virus	2001	66
Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients Michael Maschan, Paolo F. Caimi, Jane Reese‐Koc, Nature Communications	2021	66
Evaluation of Adenoviral Vectors by Flow Cytometry Linda Weaver, Michael J. Kadan Methods Antiviral TherapyPathologyVirologyCytometryAdenoviral Vectors	2000	35
Characterization of <sup>125</sup>I‐Lysergic Acid Diethylamide Binding to Serotonin Receptors in Rat Frontal Cortex Michael J. Kadan, A.M. Krohn, Mark J. Evans, Journal of Neurochemistry	1984	30
A Versatile Framework for the Design of Ligand-Dependent, Transgene-Specific Transcription Factors Ling Xu, Dennis Zerby, Ying Huang, Molecular Therapy	2001	23

Page 1